Cargando…

Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction

HIV cannot be cured by current antiretroviral therapy (ART) because it persists in a transcriptionally silent form in long-lived CD4+ cells. Leading efforts to develop a functional cure have prioritized latency reversal to expose infected cells to immune surveillance, coupled with enhancement of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Hongbing, Wallace, Zoë, Dorrell, Lucy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288286/ https://www.ncbi.nlm.nih.gov/pubmed/30564246 http://dx.doi.org/10.3389/fimmu.2018.02861

Ejemplares similares

Editorial: Immune Surveillance of the HIV Reservoir: Mechanisms, Therapeutic Targeting and New Avenues for HIV Cure
por: Prado, Julia G., et al.
Publicado: (2020)

Targeting HIV-1 reservoirs in T cell subsets
por: Li, Min, et al.
Publicado: (2023)

Targeting the Brain Reservoirs: Toward an HIV Cure
por: Marban, Céline, et al.
Publicado: (2016)

Targeting NK Cells for HIV-1 Treatment and Reservoir Clearance
por: Duan, Siqin, et al.
Publicado: (2022)

Immune mobilising T cell receptors redirect polyclonal CD8(+) T cells in chronic HIV infection to form immunological synapses
por: Wallace, Zoë, et al.
Publicado: (2022)

Combination strategies to durably suppress HIV-1: Soluble T cell receptors
por: Wallace, Zoë, et al.
Publicado: (2022)

Th17 CD4+ T-Cell as a Preferential Target for HIV Reservoirs
por: Renault, Constance, et al.
Publicado: (2022)

The HIV Reservoir in Monocytes and Macrophages
por: Wong, Michelle E., et al.
Publicado: (2019)

Targeting Cellular and Tissue HIV Reservoirs With Toll-Like Receptor Agonists
por: Macedo, Amanda B., et al.
Publicado: (2019)

Blocking Formation of the Stable HIV Reservoir: A New Perspective for HIV-1 Cure
por: Goonetilleke, Nilu, et al.
Publicado: (2019)

Corrigendum: The HIV Reservoir in Monocytes and Macrophages
por: Wong, Michelle E., et al.
Publicado: (2019)

Have Cells Harboring the HIV Reservoir Been Immunoedited?
por: Huang, Szu-Han, et al.
Publicado: (2019)

Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV Reservoirs
por: Brockman, Mark A., et al.
Publicado: (2015)

Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1
por: Sanz, Marta, et al.
Publicado: (2023)

Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir
por: Suryawanshi, Poonam, et al.
Publicado: (2021)

The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like
por: Darcis, Gilles, et al.
Publicado: (2019)

Platelets in HIV: A Guardian of Host Defence or Transient Reservoir of the Virus?
por: Pretorius, Etheresia
Publicado: (2021)

The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency
por: de Armas, Lesley R., et al.
Publicado: (2021)

Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology
por: Mylvaganam, Geetha, et al.
Publicado: (2019)

The HIV-1 latent reservoir is largely sensitive to circulating T cells
por: Warren, Joanna A, et al.
Publicado: (2020)

Quinine—When to Give It and How to Give It
por: Banchelle, L. B.
Publicado: (1887)

Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions
por: Kopycinski, Jakub, et al.
Publicado: (2023)

Therapeutic strategies for gastric cancer targeting immune cells: Future directions
por: Zhao, Yan, et al.
Publicado: (2022)

Evolving Strategies to Eliminate the CD4 T Cells HIV Viral Reservoir via CAR T Cell Immunotherapy
por: York, Jarrod, et al.
Publicado: (2022)

Targeting Immune Checkpoint Molecules to Eliminate Latent HIV
por: Boyer, Zoe, et al.
Publicado: (2018)

Follicular CD4 T Helper Cells As a Major HIV Reservoir Compartment: A Molecular Perspective
por: Aid, Malika, et al.
Publicado: (2018)

Are HIV-1-Specific Antibody Levels Potentially Useful Laboratory Markers to Estimate HIV Reservoir Size? A Review
por: Zaongo, Silvere D., et al.
Publicado: (2021)

Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease
por: Wu, Meng, et al.
Publicado: (2023)

Evaluation of the immunogenicity and impact on the latent HIV-1 reservoir of a conserved region vaccine, MVA.HIVconsv, in antiretroviral therapy-treated subjects
por: Hancock, Gemma, et al.
Publicado: (2017)

Are Fc Gamma Receptor Polymorphisms Important in HIV-1 Infection Outcomes and Latent Reservoir Size?
por: Lamptey, Helena, et al.
Publicado: (2021)

How autophagy, a potential therapeutic target, regulates intestinal inflammation
por: Chen, Shuang-Lan, et al.
Publicado: (2023)

Hepatitis B Virus Vaccination in HIV-1-Infected Young Adults: A Tool to Reduce the Size of HIV-1 Reservoirs?
por: Bekele, Yonas, et al.
Publicado: (2018)

HIV-1 Infection and Glucose Metabolism Reprogramming of T Cells: Another Approach Toward Functional Cure and Reservoir Eradication
por: Kang, Shuang, et al.
Publicado: (2020)

Lessons to be Learned from Natural Control of HIV – Future Directions, Therapeutic, and Preventive Implications
por: Shasha, David, et al.
Publicado: (2013)

How to Give Mercury
Publicado: (1901)

Where and How to Give
Publicado: (1903)

How to Give Digitalis
Publicado: (1900)

How to Give Iron
Publicado: (1887)

How to Give Iron
Publicado: (1888)

Targeting CCR5 as a Component of an HIV-1 Therapeutic Strategy
por: Mohamed, Hager, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9d37lc2271f7gk2itmanvf1jcu